QIM 5: Proportion of regular clients with diabetes with an influenza immunisation status recorded in their GP record within the previous 15 months

Influenza is a common disease of the respiratory tract. It affects people of all ages. It is estimated that influenza is likely to be associated with more than 3,000 deaths and 13,500 hospitalisations each year in Australia, just in people aged >50 years (ATAGI 2018).

There are a number of groups who are at a higher risk of influenza and its complications. These groups experience higher illness and death associated with influenza than the rest of the population and patients with diabetes is one of the vulnerable population groups. Therefore, annual influenza vaccination is strongly recommended for patients with diabetes (ATAGI 2018).

While best practice guidelines recommend annual immunisation, a 15-month interval allows for cases when a client decides to receive a vaccine earlier than recommended (e.g. from a pharmacy), or delay and wait for the release of an ‘enhanced’ vaccine (Department of Health 2020).

Capture of results recorded outside of the general practice setting

Some patients may receive care from other practitioners in addition to a GP including an endocrinologist/a specialist physician, and/or other health care providers to safely manage their diabetes (RACGP 2020). Results arising from clinical intervention conducted outside of the service that are known and recorded by the practice are included in the measure. Where the immunisation was provided elsewhere (for example, pharmacy, work place etc.) and the information is not recorded in the clinical information system of the client’s usual general practice (for example, due to incompatible clinical information system between a practice and another service), then these data will not be captured in the report.

Other sources of relevant data

Data on the prevalence of long-term health conditions like diabetes are captured in the National Health Survey (NHS) conducted by the Australian Bureau of Statistics (ABS). There are other administrative data collections where the data from these client-provider interactions are captured, e.g. Medicare Benefits Schedule (MBS), the National Diabetes Service Scheme (NDSS) register, and the Australasian Paediatric Endocrine Groups (APEG) state and territory registers. There are other administrative data collections where the data on influenza immunisation are captured, e.g. the Australian Immunisation Register (AIR).

This indicator reports on the proportion of regular clients with Type 1 or Type 2 diabetes, or an undefined diabetes diagnosis, hereafter described as diabetes, who had an influenza immunisation status recoded in their GP record within the previous 15 months. 

As of July 2021, nationally, 58.2% of regular clients with diabetes, had an influenza immunisation status recorded in their GP record within the previous 15 months. This varied from 42.0% to 68.7% across PHNs.

Figure 33: Proportion of regular clients with diabetes (Type 1, Type 2, undefined) with an influenza immunisation status recorded in their GP record within the previous 15 months, by PHN, July 2021

Figure 33: Proportion of regular clients with diabetes (Type 1, Type 2, undefined) with an influenza immunisation recorded in their GP record within the previous 15 months, by PHN, July 2021

Nationally, between October 2020 and July 2021, the proportion of regular clients with Type 1 or Type 2 diabetes, or an undefined diabetes diagnosis who had an influenza immunisation status recorded in their GP record within the previous 15 months, increased by 5.5%, from 52.7% to 58.2%.

Figure 34: Proportion of regular clients with diabetes (Type 1, Type 2, undefined) with an influenza immunisation status recorded in their GP record within the previous 15 months, October 2020 to July 2021

Figure 34: Proportion of regular clients with diabetes (Type 1, Type 2, undefined) with an influenza immunisation recorded in their GP record within the previous 15 months, October 2020 to July 2021

Proportion of regular clients with diabetes with an influenza immunisation status recorded in their GP record within the previous 15 months, by age and sex

As of July 2021, nationally, the proportion of regular clients with Type 1 or Type 2 diabetes, or an undefined diabetes diagnosis who had an influenza immunisation status recorded in their GP record within the previous 15 months was:

  • highest in the 65 years and over age group for both females (72.0%) and males (71.6%).
  • lowest in the 25–34 years age group for both females (30.6%) and males (24.6%).highest in the 65 years and over age group for both females (72.0%) and males (71.6%).
  • lowest in the 25–34 years age group for both females (30.6%) and males (24.6%).

Figure 35: Proportion of regular clients with diabetes (Type 1, Type 2, undefined) with an influenza immunisation status recorded in their GP record within the previous 15 months, by age and sex, July 2021

Figure 35: Proportion of regular clients with diabetes (Type 1, Type 2, undefined) with an influenza immunisation recorded in their GP record within the previous 15 months, by age and sex, July 2021